June 9, 2016 by Chain Drug Review
Alex Gourlay, Ornella Barra, Rite Aid Corp., Walgreens Boots Alliance Inc., WBA
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Top Walgreens Boots Alliance (WBA) executives Alex Gourlay and Ornella Barra have been appointed as co-chief operating officers as part of a realignment of the company’s senior management team. WBA said Thursday that the naming of Gourlay and Barra as co-COOs will help streamline the management of its global operations, which have
May 27, 2016 by CDR Blog
Nasdaq, Red Nose Day, Skip Bourdo, Walgreens, Walgreens Boots Alliance, WBA
CDR Blog
Walgreens Boots Alliance brought the celebration of its Red Nose Day efforts to the floor of the Nasdaq stock exchange. On Thursday, Skip Bourdo, corporate operations vice president at Walgreens, and Christy Gibb of the Comic Relief Board of Trustees rang the Nasdaq opening bell. Representatives from Red Nose Day 2016 partners NBC Universal and
May 23, 2016 by Chain Drug Review
Barry Rosenstein, Dominic Murphy, James Skinner, JANA Partners, KKR, Kohlberg Kravis Roberts, Stefano Pessina, Walgreens Boots Alliance, WBA
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — Activist investor Barry Rosenstein, managing partner of hedge fund JANA Partners LLC, has stepped down from the Walgreens Boots Alliance (WBA) Inc. board after reducing his investment in the company. WBA said late Friday that Rosenstein, who has been a director since September 2014, was slated to end his service on the
May 5, 2016 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Steven Collis, Walgreens, Walgreens Boots Alliance, Walgreens Boots Alliance Development, WBA, WBAD
Business, Featured Articles, Leading Headlines, Supplier News
VALLEY FORGE, Pa. — AmerisourceBergen Corp. has extended its strategic partnership with Walgreens Boots Alliance (WBA) Inc. for another three years. AmerisourceBergen said Thursday that its drug distribution contract with WBA and relationship with Walgreens Boots Alliance Development (WBAD) have been lengthened to 2026. AmerisourceBergen and then-merger partners Walgreen Co. and Alliance Boots had announced
April 16, 2016 by Sue Mitchell and Chain Drug Review
Australia, Boots, Boots the Chemist, Ken Murphy, Pharmacy Guild of Australia, Priceline, Sigma, Sixth Community Pharmacy Agreement, Terry White Group, Walgreens Boots Alliance, WBA
2016, Business, Issue 04-18-2016, Issues, News, Retail News
SYDNEY, Australia — Almost 100 years ago Australian pharmacists banded together to stop Boots the Chemist entering their market by setting up the Pharmacy Guild of Australia and successfully lobbying governments to enact laws restricting pharmacy location and ownership. Walgreens Boots Alliance Inc. (WBA) can expect a similarly frosty reception when it tries once again
April 5, 2016 by John Schultz and Chain Drug Review
AmerisourceBergen, Rite Aid, second quarter, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) reported double-digit revenue growth for its fiscal 2016 second quarter, with adjusted earnings per share topping Wall Street’s consensus forecast. WBA said Tuesday that second-quarter sales climbed 13.6% to $30.18 billion from $26.57 billion a year earlier. The gain stemmed largely from the full consolidation of Alliance Boots
March 25, 2016 by CDR Blog
Adam Fein, AmerisourceBergen, Drug Channels Institute, OptumRx, Pembroke Consulting, Rite Aid, Walgreens Boots Alliance, WBA
CDR Blog
The presence of Walgreens Boots Alliance (WBA) across the pharmacy care sector continues to broaden and deepen. Over two days earlier this month, WBA unveiled an integrated pharmacy offering with PBM OptumRx and then announced that it’s boosting its equity stake in drug distributor AmerisourceBergen. The highlight of the offering with OptumRx is that members
March 18, 2016 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Ornella Barra, Steven Collis, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — As part of a long-term partnership announced three years ago, Walgreens Boots Alliance (WBA) is enlarging its equity stake in AmerisourceBergen. WBA said Friday that it has exercised warrants to buy more than 22,696,912 shares of AmerisourceBergen common stock for about $1.17 billion. The transaction was funded with cash on hand, and
January 27, 2016 by Chain Drug Review
Alliance Boots, James Skinner, Rite Aid, Stefano Pessina, Valeant Pharmaceuticals, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — Walgreens Boots Alliance’s deal to acquire Rite Aid and partnership with Valeant Pharmaceuticals will build on WBA’s strong start in its first full year as a unified company, executive vice chairman and CEO Stefano Pessina said here at the annual shareholders meeting. “I am happy to say that we are on track
January 7, 2016 by Chain Drug Review
Alliance Boots, Duane Reade, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) topped Wall Street’s earnings projections for its fiscal 2016 first quarter. WBA said Thursday that for the first quarter ended Nov. 30, 2015, adjusted net earnings attributable to Walgreens Boots Alliance were $1.13 billion, or $1.03 per diluted share, compared with $749 million, or 78 cents per diluted
December 21, 2015 by Chain Drug Review
George Fairweather, Rite Aid, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) Inc. has completed $12.8 billion in term loan facilities as part of the financing for its $17.2 billion deal to acquire Rite Aid Corp. WBA said Monday that the transactions include the placement of $5 billion of term loan facilities — split between two tranches of $2.5 billion
November 23, 2015 by Geoff Walden and Chain Drug Review
Rite Aid, Walgreens, Walgreens Boots Alliance, WBA
2015, Featured Articles, Issue 11-23-2015, Issues, Leading Headlines, News
DEERFIELD, Ill. — Estimates vary widely on the number of stores Walgreens Boots Alliance Inc. (WBA) will divest as part of its $17.2 billion acquisition of Rite Aid Corp. In a filing with the Securities and Exchange Commission, WBA said the deal allows for up to 1,000 outlets to be closed or sold “if required
November 2, 2015 by Chain Drug Review
Rite Aid, Securities and Exchange Commission, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) Inc. has indicated that as many as 1,000 stores could be divested to gain regulatory approval for its deal to acquire Rite Aid Corp. In an investor presentation filed Monday with the Securities and Exchange Commission, WBA said the the $17.2 billion merger agreement allows for up to
March 13, 2015 by Chain Drug Review and Chain Drug Review
Nasdaq OMX Group, Nasdaq-100, Walgreens Boots Alliance, WBA
Business, Leading Headlines, News, Retail News
NEW YORK — The Walgreens Boots Alliance Inc. is slated to become part of the Nasdaq-100 Index later this month. The Nasdaq OMX Group Inc. said Friday that Walgreens Boots Alliance, which has the stock symbol WBA, will become a component of the Nasdaq-100 Index (NDX), Nasdaq-100 Equal Weighted Index (NDXE) and NASDAQ-100 Ex-Technology Index